Is Fabrinet (FN) a risky stock?
As of July 27, 2026, Clavix grades Fabrinet (FN) D+ for risk, a composite score of 43 out of 100 on an A+ to F scale, which puts FN in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
FN price, last 3 months
FN's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind FN's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how FN scores on each, as of July 27, 2026.
What's moving FN's risk right now
Company-specific signals Clavix flags behind FN's current grade, drawn from recent news and filings as of July 27, 2026.
Wall Street Zen cut its rating on Fabrinet to Hold, and combined with JPMorgan trimming its price target, signals weakening Wall Street confidence in the stock's near-term upside. This could discourage institutional buying.
Needham lowered its price target on Fabrinet to $150 per share, even though it still rates the stock favorably. The cut points to more cautious near-term expectations for the shares.
Implied volatility on Fabrinet's December 2026 $220 call options has surged, suggesting traders expect a big move in the stock down the road. The signal is mixed since the direction of any move is unclear.
Recent FN news
The latest headlines Clavix ingested for Fabrinet, newest first. These feed the news-sentiment dimension of FN's grade.
-
Recent options trading in Fabrinet (FN) has pushed the December 2026 $220 call into the group of contracts with the highest implied volatility, signaling expectations of a sizeable share price move. The article suggests FN could be 29% undervalued based on this options activity.
What a D+ grade means
On the Clavix A+ to F scale, FN's composite of 43 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell FN or any security. Grades are risk indicators, not predictions of return. Data may be delayed.